Halfway thru the year and we are fast approaching
Post# of 7791
(Total Views: 315)
Posted On: 07/16/2024 6:26:01 AM
Halfway thru the year and we are fast approaching 01 Jan 2025, the enactment date for the NOPAIN Act. I don’t know what the process is for BIEL to be accepted into the program. I AM sure that there IS a process. I have written extensively on all things BIEL for several years so I leave it up to the reader to re-read should you be so inclined. I don’t offer myself up as an insider or have insider knowledge via secret back channels. I am NOT that guy and have no desire to be that guy. All my comments are my opinion and based on freely available information.
This company is flying under the radar for most people and most investors. There is a reason for this. PEMF, and the products based upon the science, is an anathema to the Rockefeller (nee: Rokkenfelder) based, drugs and surgery only, profit-driven western medicine. Money talks, and more specifically, it shouts and dictates. There is (are?) volumes of material to substantiate the facts. Media plays a huge part. The same people controlling the media are bosom buddies w/ the same pscho-paths who control the medical establishment and, yes, they do, also, control and ‘own’ money. The bumper sticker is: “The Central Problem is Central Banking”. Do your homework. We are all victims of the three M’s: Money, Media, Medical.
I talk to people all the time about Actipatch. I have a first-rate, 5 min. elevator pitch, well -honed over the years. The latest was 3 days ago, details don’t matter. Word of mouth only goes so far. Grassroots activism is ideal but takes time that we don’t have. And thus, it comes round to The NOPAIN Act which is essential to the USA adoption of PEMF as expressed via RecoveryRx, and any & all other products such as a rechargeable device, a surgery incision device, and OA thumb device. The vet/pet product is a stand-alone but potentially large moneymaker.
Oddly enough, the profit-driven mania surrounding current medical practice is the same motivation for adoption of BIEL PEMF products into the mass marketplace via The NOPAIN Act, i.e. - money. Go figure, pun intended. Which, of course, brings us full circle to what preoccupies most investors and message board posters alike, myself included, and that is, a buyout vis-a-vis The NOPAIN Act. This ‘transition’, should it happen, is tantamount to a car entering a ramp going at 10 mph onto an interstate highway and in the very next second is traveling at 68 mph on the interstate highway.
In between 10 and 68 is a full menu of presumptions and improbabilities that take years to come to fruition; lots and lots of dedicated work. BIEL is an outlier until it isn’t. My guess is any announcement would come 'out-of-the-blue’, seemingly, but in reality (if truth be known) has been building a full head of steam for quite awhile, hidden in plain sight. Think of one of those pscho-pictures that are supposed to depict a girl picking flowers in a field when most people only see a bunch of stupid dots that looks like nothing. Imagination plays a part but is it all smoke & mirrors, only wishful thinking on our part?
For a short while I did try to find out what I could about CPT codes being assigned to BIEL and thinking that being the sole prelude to being accepted by CMMS. Naivete personified. What I discovered is mountains of red tape that would dwarf the Alps, the Rockies, the Andes and the Himalayas all rolled into one. The levels of complexity, inter-connectedness of agencies and hundreds of 3 & 4 letter acronyms is mind-boggling; a lawyers’ dream, a layman’s nightmare and a bureaucrat’s fantasyland.
Much has been made of Dr. Koneru and Keith Nalepka leaving the company. Dr. Koneru going to Viant (worldwide medical device maker) and Keith going to VLMS Global Healthcare (medical coding, i.e. - CPT codes). It doesn’t take much ‘imagination’ to see how these ‘departures’ fit into the big picture, if indeed, a big picture exists. I see these ‘departures’ as deploying your assets to make the best use of them. Think in terms of the previous paragraph. Preparing the ‘ramp’ for the ‘out-of-blue’ transition is a massive undertaking. This is my OPINION. DO NOT READ ANYTHING INTO THIS OTHER THAN THAT.
Let’s talk numbers. BIEL has 24 billion shares outstanding. I will presume a buyer pays $0.10 per share which is $2.4 billion dollars. How does one justify that amount in terms of current income of BIEL? In short, you don’t. You look at market potential which is what a buyer does. Large corporations have entire departments devoted exclusively to M&A, Mergers & Acquisitions. SWOT analysis is a common business practice. Do some research on chronic pain, phantom pain sufferers, arthritis, opioid abuse, general pain issues and you will soon see a (USA) market potential in the 100’s of millions pain incidents where most, if not all, can be relieved and/or eliminated through the use of PEMF device such as RecoveryRx, a prescription (a key differentiation) product. We are the drug-free, adverse-event free, side-effect free antidote to Opioid abuse.
Let’s also presume, if accepted thru the The NOPAIN Act, a $20 profit margin on each device. On one veteran-owned website, RecoveryRx is listed for $250. Do the math w/ ‘only’ 50 million units sold annually. That is $1 billion profit meaning in less than 3 years the investment of $2.4 billion has been fully recovered. And here’s the best part - that is recurring profit, year after year … Should BIEL get accepted into CMMS via the NPA then the VA and DOD will follow suit. This is the USA market, excluding Canada, Australia, Europe, Asia and the Middle East.
So, there you have it. Take it or leave it. We, as investors, are never going to get any indications one way or the other. For me, there is no debate. The economic argument of acceptance is painfully (again, pun intended) obvious. To say that NDAs are in effect is an understatement. And even more to the point, if an insignificant message board poster can make the case, then maybe a well-funded, well-trained, ‘plugged-in’ M&A department might be able to???
Hope for the best, Prepare for the worst. Adapt - Improvise - Overcome
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
P.S. - I have a cat named Andy, named after, and in honor of, Andy Whelan, the Founder of Bioelectronics, maker of Actipatch and RecoveryRx. Andy is a warrior w/ cojones. Andy is a free-range cat in that he is free to go wherever he pleases, whenever he pleases. One night, snowing, wind howling, wind chill at -20 degrees, Andy survived and showed up the next day. He braved the worst and carried on. He’s like that, ya know. We, the investors of BIEL, will carry on in the same tradition. We have braved the worst. Many good people are working on our behalf. I pray for them daily and so should you.
This company is flying under the radar for most people and most investors. There is a reason for this. PEMF, and the products based upon the science, is an anathema to the Rockefeller (nee: Rokkenfelder) based, drugs and surgery only, profit-driven western medicine. Money talks, and more specifically, it shouts and dictates. There is (are?) volumes of material to substantiate the facts. Media plays a huge part. The same people controlling the media are bosom buddies w/ the same pscho-paths who control the medical establishment and, yes, they do, also, control and ‘own’ money. The bumper sticker is: “The Central Problem is Central Banking”. Do your homework. We are all victims of the three M’s: Money, Media, Medical.
I talk to people all the time about Actipatch. I have a first-rate, 5 min. elevator pitch, well -honed over the years. The latest was 3 days ago, details don’t matter. Word of mouth only goes so far. Grassroots activism is ideal but takes time that we don’t have. And thus, it comes round to The NOPAIN Act which is essential to the USA adoption of PEMF as expressed via RecoveryRx, and any & all other products such as a rechargeable device, a surgery incision device, and OA thumb device. The vet/pet product is a stand-alone but potentially large moneymaker.
Oddly enough, the profit-driven mania surrounding current medical practice is the same motivation for adoption of BIEL PEMF products into the mass marketplace via The NOPAIN Act, i.e. - money. Go figure, pun intended. Which, of course, brings us full circle to what preoccupies most investors and message board posters alike, myself included, and that is, a buyout vis-a-vis The NOPAIN Act. This ‘transition’, should it happen, is tantamount to a car entering a ramp going at 10 mph onto an interstate highway and in the very next second is traveling at 68 mph on the interstate highway.
In between 10 and 68 is a full menu of presumptions and improbabilities that take years to come to fruition; lots and lots of dedicated work. BIEL is an outlier until it isn’t. My guess is any announcement would come 'out-of-the-blue’, seemingly, but in reality (if truth be known) has been building a full head of steam for quite awhile, hidden in plain sight. Think of one of those pscho-pictures that are supposed to depict a girl picking flowers in a field when most people only see a bunch of stupid dots that looks like nothing. Imagination plays a part but is it all smoke & mirrors, only wishful thinking on our part?
For a short while I did try to find out what I could about CPT codes being assigned to BIEL and thinking that being the sole prelude to being accepted by CMMS. Naivete personified. What I discovered is mountains of red tape that would dwarf the Alps, the Rockies, the Andes and the Himalayas all rolled into one. The levels of complexity, inter-connectedness of agencies and hundreds of 3 & 4 letter acronyms is mind-boggling; a lawyers’ dream, a layman’s nightmare and a bureaucrat’s fantasyland.
Much has been made of Dr. Koneru and Keith Nalepka leaving the company. Dr. Koneru going to Viant (worldwide medical device maker) and Keith going to VLMS Global Healthcare (medical coding, i.e. - CPT codes). It doesn’t take much ‘imagination’ to see how these ‘departures’ fit into the big picture, if indeed, a big picture exists. I see these ‘departures’ as deploying your assets to make the best use of them. Think in terms of the previous paragraph. Preparing the ‘ramp’ for the ‘out-of-blue’ transition is a massive undertaking. This is my OPINION. DO NOT READ ANYTHING INTO THIS OTHER THAN THAT.
Let’s talk numbers. BIEL has 24 billion shares outstanding. I will presume a buyer pays $0.10 per share which is $2.4 billion dollars. How does one justify that amount in terms of current income of BIEL? In short, you don’t. You look at market potential which is what a buyer does. Large corporations have entire departments devoted exclusively to M&A, Mergers & Acquisitions. SWOT analysis is a common business practice. Do some research on chronic pain, phantom pain sufferers, arthritis, opioid abuse, general pain issues and you will soon see a (USA) market potential in the 100’s of millions pain incidents where most, if not all, can be relieved and/or eliminated through the use of PEMF device such as RecoveryRx, a prescription (a key differentiation) product. We are the drug-free, adverse-event free, side-effect free antidote to Opioid abuse.
Let’s also presume, if accepted thru the The NOPAIN Act, a $20 profit margin on each device. On one veteran-owned website, RecoveryRx is listed for $250. Do the math w/ ‘only’ 50 million units sold annually. That is $1 billion profit meaning in less than 3 years the investment of $2.4 billion has been fully recovered. And here’s the best part - that is recurring profit, year after year … Should BIEL get accepted into CMMS via the NPA then the VA and DOD will follow suit. This is the USA market, excluding Canada, Australia, Europe, Asia and the Middle East.
So, there you have it. Take it or leave it. We, as investors, are never going to get any indications one way or the other. For me, there is no debate. The economic argument of acceptance is painfully (again, pun intended) obvious. To say that NDAs are in effect is an understatement. And even more to the point, if an insignificant message board poster can make the case, then maybe a well-funded, well-trained, ‘plugged-in’ M&A department might be able to???
Quote:
THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
Hope for the best, Prepare for the worst. Adapt - Improvise - Overcome
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
P.S. - I have a cat named Andy, named after, and in honor of, Andy Whelan, the Founder of Bioelectronics, maker of Actipatch and RecoveryRx. Andy is a warrior w/ cojones. Andy is a free-range cat in that he is free to go wherever he pleases, whenever he pleases. One night, snowing, wind howling, wind chill at -20 degrees, Andy survived and showed up the next day. He braved the worst and carried on. He’s like that, ya know. We, the investors of BIEL, will carry on in the same tradition. We have braved the worst. Many good people are working on our behalf. I pray for them daily and so should you.
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼